Idorsia Ltd. (IDRSF)
5.30
-0.30
(-5.36%)
USD |
OTCM |
Sep 24, 16:00
Idorsia Cash from Operations (TTM) : -161.54M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -161.54M |
| March 31, 2026 | -171.00M |
| December 31, 2025 | -211.27M |
| September 30, 2025 | -164.21M |
| June 30, 2025 | -250.27M |
| March 31, 2025 | -305.28M |
| December 31, 2024 | -366.33M |
| September 30, 2024 | -484.07M |
| June 30, 2024 | -454.15M |
| March 31, 2024 | -560.32M |
| December 31, 2023 | -695.27M |
| September 30, 2023 | -799.39M |
| June 30, 2023 | -915.66M |
| March 31, 2023 | -913.77M |
| December 31, 2022 | -901.05M |
| September 30, 2022 | -886.41M |
| June 30, 2022 | -810.52M |
| March 31, 2022 | -736.77M |
| Date | Value |
|---|---|
| December 31, 2021 | -644.95M |
| September 30, 2021 | -566.87M |
| June 30, 2021 | -539.79M |
| March 31, 2021 | -447.19M |
| December 31, 2020 | -390.89M |
| September 30, 2020 | -381.85M |
| June 30, 2020 | -408.49M |
| March 31, 2020 | -465.03M |
| December 31, 2019 | -465.16M |
| September 30, 2019 | -462.89M |
| June 30, 2019 | -431.60M |
| March 31, 2019 | -394.58M |
| December 31, 2018 | -359.65M |
| September 30, 2018 | -86.81M |
| June 30, 2018 | -48.65M |
| March 31, 2018 | 119.06M |
| December 31, 2017 | 97.26M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Basilea Pharmaceutica AG | 75.01M |
| Santhera Pharmaceuticals Holding AG | -43.47M |
| BeOne Medicines Ltd. | 1.488B |
| AC Immune SA | -- |
| CRISPR Therapeutics AG | -369.58M |